William Blair says Applied Therapeutics (APLT)’ complete response letter from the FDA for govorestat for the treatment of galactosemia is “unexpected and disappointing.” Given the lack of information ...
The pharma company's shares are getting crushed after regulators decline to green light a drug to treat a rare disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback